Trinity Biotech plc (ADR) (NASDAQ:TRIB)

CAPS Rating: 5 out of 5

The Company develops, acquires, manufactures and markets medical diagnostic products for the clinical laboratory and point-of-care segments of the diagnostic market.

Recs

0
Player Avatar knudfool (97.73) Submitted: 3/17/2011 10:53:51 PM : Outperform Start Price: $9.20 TRIB Score: +18.61

Growth business with great margins and a cash safety margin.

Featured Broker Partners


Advertisement